BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou JD, Lin J, Zhang TJ, Ma JC, Yang L, Wen XM, Guo H, Yang J, Deng ZQ, Qian J. GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome. Cancer Med 2017;6:267-74. [PMID: 27891827 DOI: 10.1002/cam4.984] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang TJ, Xu ZJ, Wen XM, Gu Y, Ma JC, Yuan Q, Lin J, Zhou JD, Qian J. SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm. Leukemia 2022. [PMID: 35906386 DOI: 10.1038/s41375-022-01659-1] [Reference Citation Analysis]
2 Zhou J, Xu Z, Jin Y, Zhang X, Gu Y, Ma J, Wen X, Lin J, Zhang T, Qian J. Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes. Front Oncol 2022;12:897898. [DOI: 10.3389/fonc.2022.897898] [Reference Citation Analysis]
3 Gonçalves AC, Alves R, Baldeiras I, Marques B, Oliveiros B, Pereira A, Nascimento Costa JM, Cortesão E, Mota Vieira L, Sarmento Ribeiro AB. DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome-Relevance as Complementary Prognostic Biomarkers. Cancers (Basel) 2021;13:3138. [PMID: 34201739 DOI: 10.3390/cancers13133138] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol 2021;184:114365. [PMID: 33310051 DOI: 10.1016/j.bcp.2020.114365] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 Shaaban Y, Aref S, Taalab M, Ayed M, Mabed M. Implications of Glutathione Peroxidase 3 Expression in a Cohort of Egyptian Patients with Acute Myeloid Leukemia. Asian Pac J Cancer Prev 2020;21:3567-72. [PMID: 33369453 DOI: 10.31557/APJCP.2020.21.12.3567] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zhou JD, Zhang TJ, Xu ZJ, Deng ZQ, Gu Y, Ma JC, Wen XM, Leng JY, Lin J, Chen SN, Qian J. Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes. Cell Death Dis 2020;11:997. [PMID: 33219204 DOI: 10.1038/s41419-020-03213-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bond DR, Lee HJ, Enjeti AK. Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy. Cancers (Basel) 2020;12:E3128. [PMID: 33114584 DOI: 10.3390/cancers12113128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yang S, Gao T, Zheng Z, Lai B, Sheng L, Xu Z, Yan X, Wang J, Duan S, Ouyang G. GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da. J Int Med Res 2020;48:300060520956894. [PMID: 32967500 DOI: 10.1177/0300060520956894] [Reference Citation Analysis]
9 Brigelius-flohé R, Flohé L. Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxidants & Redox Signaling 2020;33:498-516. [DOI: 10.1089/ars.2019.7905] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 40.0] [Reference Citation Analysis]
10 Zhang TJ, Xu ZJ, Gu Y, Wen XM, Ma JC, Zhang W, Deng ZQ, Leng JY, Qian J, Lin J, Zhou JD. Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms. Clin Transl Med 2020;10:e29. [PMID: 32508046 DOI: 10.1002/ctm2.29] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
11 Liang S, Zhou X, Pan H, Yang Y, Shi L, Wang L. Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis. Hematology 2019;24:613-22. [PMID: 31482762 DOI: 10.1080/16078454.2019.1657613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhou C, Hu H, Zheng Z, Chen C, Li Y, Li B, Duan S. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis. Pathol Res Pract 2019;215:152443. [PMID: 31085009 DOI: 10.1016/j.prp.2019.152443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Zhou C, Pan R, Li B, Huang T, Zhao J, Ying J, Duan S. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Future Oncol 2019;15:1279-89. [PMID: 30924352 DOI: 10.2217/fon-2018-0674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
14 Zhao G, Li N, Li S, Wu W, Wang X, Gu J. High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome. Int J Oncol 2019;54:491-504. [PMID: 30535457 DOI: 10.3892/ijo.2018.4652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
15 Han L, Yang X, Sun W, Li Z, Ren H, Li B, Zhang R, Zhang D, Shi Z, Liu J, Cao J, Zhang J, Xiong Y. The study of GPX3 methylation in patients with Kashin-Beck Disease and its mechanism in chondrocyte apoptosis. Bone 2018;117:15-22. [PMID: 30153510 DOI: 10.1016/j.bone.2018.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhou JD, Wang YX, Zhang TJ, Li XX, Gu Y, Zhang W, Ma JC, Lin J, Qian J. Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies. Clin Epigenetics 2018;10:92. [PMID: 30002740 DOI: 10.1186/s13148-018-0523-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
17 Dexheimer GM, Alves J, Reckziegel L, Lazzaretti G, Abujamra AL. DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome. Dis Markers 2017;2017:5472893. [PMID: 29038614 DOI: 10.1155/2017/5472893] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
18 Zhou JD, Lin J, Zhang TJ, Ma JC, Yang L, Wen XM, Guo H, Yang J, Deng ZQ, Qian J. GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome. Cancer Med 2017;6:267-74. [PMID: 27891827 DOI: 10.1002/cam4.984] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]